Torray Investment Partners LLC Has $19.53 Million Stock Position in UnitedHealth Group Incorporated $UNH

Torray Investment Partners LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 59,153 shares of the healthcare conglomerate’s stock after acquiring an additional 2,047 shares during the quarter. UnitedHealth Group makes up about 2.8% of Torray Investment Partners LLC’s portfolio, making the stock its 14th largest holding. Torray Investment Partners LLC’s holdings in UnitedHealth Group were worth $19,527,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Beacon Financial Strategies CORP bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at $26,000. Foster Dykema Cabot & Partners LLC boosted its stake in shares of UnitedHealth Group by 69.4% in the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 34 shares during the last quarter. 1248 Management LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $29,000. Holos Integrated Wealth LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at $29,000. Finally, Hurley Capital LLC boosted its stake in UnitedHealth Group by 81.6% during the third quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 40 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

UNH has been the topic of several research analyst reports. Sanford C. Bernstein increased their target price on shares of UnitedHealth Group from $405.00 to $411.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 7th. Argus raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 target price on the stock in a research note on Wednesday. Morgan Stanley increased their target price on shares of UnitedHealth Group from $375.00 to $395.00 and gave the stock an “overweight” rating in a research note on Wednesday. Barclays increased their target price on shares of UnitedHealth Group from $327.00 to $373.00 and gave the stock an “overweight” rating in a research note on Wednesday. Finally, KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $377.68.

UnitedHealth Group Stock Performance

NYSE UNH traded up $0.52 during trading hours on Thursday, reaching $354.04. 1,171,634 shares of the company were exchanged, compared to its average volume of 9,628,722. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $429.90. The business’s 50 day simple moving average is $290.76 and its 200-day simple moving average is $317.09. The company has a quick ratio of 0.79, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $321.35 billion, a P/E ratio of 26.76, a P/E/G ratio of 1.53 and a beta of 0.40.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter last year, the company posted $7.20 earnings per share. The firm’s quarterly revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 18.43 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were paid a $2.21 dividend. The ex-dividend date was Monday, March 9th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 67.02%.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and guidance raise — UNH reported a Q1 EPS beat and raised FY 2026 adjusted EPS guidance to above $18.25, citing improved medical-cost trends and revenue growth; that beat-and-raise is the primary driver of the intraday rally. UNH Q1 Deep Dive
• Positive Sentiment: Analyst upgrades and price‑target increases — Several firms (Argus, Morgan Stanley, RBC, Oppenheimer, Wells Fargo, Truist, Barclays, Jefferies) raised ratings or targets after the quarter, supporting further upside expectations. Analysts Increase Forecasts
• Positive Sentiment: Optum and AI investments as growth catalysts — Management outlined heavy investment in AI (about $1.5B) and growing throughput on the Optum Real claims platform, which management says will improve operating leverage and margins over time. UNH AI/Optum Real
• Positive Sentiment: Unusual bullish options activity — Elevated call volume (roughly 164k calls, ~30% above average) signals speculative and possibly institutional bullish positioning, which can amplify near‑term momentum.
• Neutral Sentiment: Market and media analysis — Multiple deep‑dive pieces and transcripts are out summarizing the quarter and management’s turnaround plan; useful for investors but largely restate the beat-and-raise. Earnings Call Transcript
• Negative Sentiment: Regulatory / program uncertainty — UnitedHealth flagged “challenges” with the Medicare obesity‑drug pilot program, creating uncertainty about future uptake or coverage that could affect medical costs or utilization. Reuters: Obesity Drug Pilot
• Negative Sentiment: Ongoing cost risk — Management and analysts still cite the risk that medical-cost trends could reaccelerate; investors should watch subsequent MCR (medical care ratio) prints and membership trends.
• Negative Sentiment: Not all analysts are uniformly bullish — One firm (Robert W. Baird) maintained an underperform stance with a lower target, a reminder that valuation and execution risk remain.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.